Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

Miskowiak, Kamilla W, Vinberg, Maj, Christensen, Ellen M, Bukh, Jens D, Harmer, Catherine J, Ehrenreich, Hannelore, Kessing, Lars V·2014·Neuropsychopharmacology
DOI 10.1038/npp.2013.335

Cited by (104)

Items 101–104 of 104

  1. Research on Effect of Erythropoietin Therapy on Cognitive Impairment and Neural Plasticity after Traumatic Brain Injury in Rats with Different Month-Age
    茜茜 迟 · 2023 · Advances in Clinical Medicine
  2. The Management of Neurocognitive Impairment in Mood Disorders
    Peter Gallagher, Allan Hunter Young · 2024 · Cambridge University Press eBooks
  3. Caractérisation des effets périphériques et centraux de l'érythropoïétine sur la sensibilité chimique à l'O2 et au CO2
    Hanan Khemiri · 2014
  4. Moderate hypoxia and cognitive training for cognitive impairment in mood disorders: a randomized controlled trial
    Johanna Mariegaard Schandorff, Viktoria Damgaard, Annette Johansen, Julian Macoveanu, Katrine Cramer, Madsen ABF, Barbara Emilie Rotbol Orum, Caroline Fussing Bruun, Morten Meyer, Pontus Plavén‐Sigray et al. · 2026 · medRxiv